Table 2: Characteristics of sample patients with significant elevations in hemoglobin concentrations following intravenous iron infusionsa.
Age (yrs) | Sex | ASA-PS | Comorbidities | Procedure | Initial Hb (g/dL) | Post iron infusion Hb (g/dL) | Hb change (g/dL) | Time interval (days) |
33 | F | 2 | Fibroids | Myomectomy | 7.4 | 9.5 | 2.1 | 14 |
45 | F | 3 | Lung cancer, Myasthenia gravis | Lung lobectomy | 10.2 | 12.6 | 2.4 | 15 |
40 | F | 2 | Pregnancy | Vaginal delivery | 8.5 | 10.8 | 2.3 | 19 |
37 | F | 2 | Twin pregnancy | Vaginal twin delivery | 9.6 | 11.4 | 1.8 | 10 |
31 | F | 2 | Gastric bypass | Cesarean delivery | 8.1 | 9.7 | 1.6 | 14 |
ASA-PS: American Society of Anesthesiologists Physical Status; F: Female; Hb: Hemoglobin.
aNo reported adverse effects or need for blood transfusions.